Metabolic research peptides in Canada
Metabolic research covers compounds studied for their action on appetite hormones, insulin release and energy use. Retatrutide and tirzepatide are incretin receptor agonists with substantial human trial records; cagrilintide is a long-acting amylin analogue. MOTS-C, AOD-9604, 5-Amino-1MQ and SLU-PP-332 have been studied mainly in rodents and cell culture, and their pages say so.
Cagrilintide
Long-acting amylin analogue (amylin receptor agonist)
from $43.00HPLC · CoA
Add 2 more to save 4%
5-Amino-1MQ
Small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor
from $62.00HPLC · CoA
Add 2 more to save 4%
AOD-9604
Modified C-terminal fragment of human growth hormone
from $57.00HPLC · CoA
Add 2 more to save 4%
How these compare
| Compound | Class | Sizes | From |
|---|---|---|---|
| Retatrutide | GIP, GLP-1 and glucagon receptor agonist | 10 mg · 20 mg · 30 mg | $87.00 |
| Tirzepatide | GIP and GLP-1 receptor agonist | 20 mg · 40 mg | $77.50 |
| Cagrilintide | Long-acting amylin analogue (amylin receptor agonist) | 5 mg · 10 mg | $43.00 |
| 5-Amino-1MQ | Small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor | 50 mg | $62.00 |
| AOD-9604 | Modified C-terminal fragment of human growth hormone | 5 mg | $57.00 |
| Retatrutide + Cagrilintide | Two-peptide research blend (GIP, GLP-1 and glucagon receptor agonist + long-acting amylin analogue) | 15 mg | $104.00 |